ZP1848 Publications
  • 2008

    27 November 2008:  Announcement no. 3, 2008: Zealand Pharma and Helsinn Healthcare S...

    Read More >

  • Product Pipeline

    Zealand's Pipeline comprises 1 compound in phase III, 1 compound in phase II, 2 c...

    Read More >

ZP1848 Publications

Petersen, Y.M., Clausen, T.S., Kjølbye, A., Ørskov, A., Petersen, J.S. Larsen, B.D., Holst, J.J. and Poulsen, S.S.:
ZP1848, a new high efficacy glucagon-like peptide 2 mimetic, prevents indomethacin-induced inflammation in the small intestine in rats.
Annual meeting - Pharmacology of Membrane Proteins: from molecule to clinic. Joint meeting between The German Pharmacological Society and The Danish Society of Pharmacology and Toxicology, 21-22 June 2007, Copenhagen, Denmark
Poster Abstract No. 20, Meeting Programme p 41
Poster

Petersen. Y.M., Clausen, T.S., Kjølbye, A., Ørskov, C., Petersen, J.S.,  Larsen, B.D., Holst, J.J. and Poulsen, S.S.:
ZP1848, a new high efficacy glucagon-like peptide 2 mimetic, prevents indomethacin-induced inflammation in the small intestine in rats.
Poster abstract for 14th United European Gastroenterology Week (UEGW 2006), 21-25 October 2006, Berlin, Germany. Poster MON-G-247
Gut, 2006, 55, Supplement No. V, A130

To top of page

Tip a friend

Fill in the form below to tip a friend about this page.






Subscribe

When this page is updated you will be updated by e-mail.



Related links